Abstract
A cannabinoid receptor antagonist, SR144385, has been labeled with fluorine-18. [18F] SR144385 was synthesized in a multi-step reaction in which fluorine-18 was introduced by nucleophilic halogen displacement on a bromo precursor. The fluorine-18 labeled intermediate was deprotected and coupled with 1-aminopiperidine to give [18F]SR144385. The time for radiosynthesis, HPLC purification, and formulation was 2 hours from end-of-bombardment. [18F] SR144385 of high radiochemical purity was obtained at end-of-synthesis with an average (n=11) specific radioactivity of 1852 mCi/μmol and an average isolated, non-decay corrected radiochemical yield of 4% from potassium [18F] fluoride. Copyright © 1999 John Wiley & Sons, Ltd.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Labelled Compounds and Radiopharmaceuticals
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
